This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CSPP Antibody
catalog :
NBP2-26101
quantity :
0.1 mg
price :
399 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, mouse, rat, dogs, bovine
application :
western blot
product information
brand :
Novus Biologicals, a Bio-Techne brand
catalog number base :
NBP2-26101
SKU :
NBP2-26101
product name :
CSPP Antibody
description :
The CSPP Antibody from Novus Biologicals is a goat polyclonal antibody to CSPP. This antibody reacts with bovine,canine,human,mouse,porcine,rat. The CSPP Antibody has been validated for the following applications: Western Blot,Peptide ELISA.
target :
CSPP
unit size :
0.1 mg
category :
Primary Antibodies
buffer :
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
clonality :
Polyclonal
concentration :
0.5 mg/ml
conjugate :
Unconjugated
host :
Goat
immunogen :
Peptide with sequence C-RQNIDAYHNPDARTY corresponding to internal region according to NP_079066.5.
isotype :
IgG
purity :
Immunogen affinity purified
species :
Bovine,Canine,Human,Mouse,Porcine,Rat
storage :
Store at -20C. Avoid freeze-thaw cycles.
gene symbol :
CSPP1
applications :
Western Blot,Peptide ELISA
USD :
399
USD 2025 :
399 USD
alt names :
Centrosome And Spindle Pole Associated Protein 1, Centrosome And Spindle Pole-Associated Protein 1, CSPP1, FLJ22490
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
questions and comments